BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 24296169)

  • 1. MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.
    ten Broeke T; Wubbolts R; Stoorvogel W
    Cold Spring Harb Perspect Biol; 2013 Dec; 5(12):a016873. PubMed ID: 24296169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions.
    ten Broeke T; van Niel G; Wauben MH; Wubbolts R; Stoorvogel W
    Traffic; 2011 Aug; 12(8):1025-36. PubMed ID: 21518167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
    Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
    J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells.
    van Niel G; Wubbolts R; Stoorvogel W
    Curr Opin Cell Biol; 2008 Aug; 20(4):437-44. PubMed ID: 18582577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
    Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
    J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
    Karlsson L
    Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MHC class II restricted antigen presentation].
    Hirata S; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():299-303. PubMed ID: 15861672
    [No Abstract]   [Full Text] [Related]  

  • 8. MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b.
    Michelet X; Garg S; Wolf BJ; Tuli A; Ricciardi-Castagnoli P; Brenner MB
    J Immunol; 2015 Mar; 194(5):2079-88. PubMed ID: 25637027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosomal localization of MHC class II-invariant chain complexes.
    Miller J
    Immunol Res; 1994; 13(4):244-52. PubMed ID: 7616052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments.
    Kang TH; Lee JH; Bae HC; Noh KH; Kim JH; Song CK; Shin BC; Hung CF; Wu TC; Park JS; Kim TW
    Immunol Lett; 2006 Aug; 106(2):126-34. PubMed ID: 16844231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant chain is a new chaperone for TLR7 in B cells.
    Tohmé M; Manoury B
    Mol Immunol; 2015 Dec; 68(2 Pt A):102-5. PubMed ID: 26198699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane specializations and endosome maturation in dendritic cells and B cells.
    Boes M; Cuvillier A; Ploegh H
    Trends Cell Biol; 2004 Apr; 14(4):175-83. PubMed ID: 15066635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The labyrinth unfolds: architectural rearrangements of the endolysosomal system in antigen-presenting cells.
    Perrin P; Jongsma ML; Neefjes J; Berlin I
    Curr Opin Immunol; 2019 Jun; 58():1-8. PubMed ID: 30738283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
    Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
    J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trafficking of MHC class II molecules in the late secretory pathway.
    Hiltbold EM; Roche PA
    Curr Opin Immunol; 2002 Feb; 14(1):30-5. PubMed ID: 11790530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The invariant chain transports TNF family member CD70 to MHC class II compartments in dendritic cells.
    Zwart W; Peperzak V; de Vries E; Keller AM; van der Horst G; Veraar EA; Geumann U; Janssen H; Janssen L; Naik SH; Neefjes J; Borst J
    J Cell Sci; 2010 Nov; 123(Pt 21):3817-27. PubMed ID: 20971706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
    Cho KJ; Ishido S; Eisenlohr LC; Roche PA
    J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways.
    Buschow SI; Nolte-'t Hoen EN; van Niel G; Pols MS; ten Broeke T; Lauwen M; Ossendorp F; Melief CJ; Raposo G; Wubbolts R; Wauben MH; Stoorvogel W
    Traffic; 2009 Oct; 10(10):1528-42. PubMed ID: 19682328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.